Impact of human immunodeficiency virus 1 infection on clinical presentation, treatment outcome and survival in a cohort of Ethiopian children with tuberculosis

Pediatric Infectious Disease Journal

Volumn 21, Issue 11, 2002, Pages 1053-1061

  Palme, Ingela Berggren ^a,c   Gudetta, Berhanu ^c   Bruchfeld, Judith ^b   Muhe, Lulu ^b   Giesecke, Johan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ADDIS ABABA UNIVERSITY   (Ethiopia)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Child; Clinic, diagnosis, treatment, outcome, Ethiopia; Human immunodeficiency virus, tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; STREPTOMYCIN; THIOACETAZONE; TUBERCULOSTATIC AGENT;

ADOLESCENT; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; ETHIOPIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MICROSCOPY; NAUSEA; OUTCOMES RESEARCH; PRIORITY JOURNAL; RASH; SURVIVAL; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TUBERCULIN TEST; TUBERCULOSIS;

ADOLESCENT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; ETHIOPIA; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; MALE; MYCOBACTERIUM TUBERCULOSIS; NUTRITIONAL STATUS; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUBERCULIN TEST; TUBERCULOSIS;

EID: 0036847527     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200211000-00016     Document Type: Article

References (35)

1. Dye C, Fengzeng Z, Scheele S, Williams B. Evaluating the impact of tuberculosis control: Number of deaths prevented by short-course chemotherapy in China. Int J Epidemiol 2000; 29:558-64.
2. Berggren Palme I, Gudetta B, Degefu H, Muhe L, Bruchfeld J, Giesecke J. A controlled estimate of the risk of HIV infection in Ethiopian children with tuberculosis. Epidemiol Infect 2001;127:517-25.
3. Madhi SA, Huebner RE, Doedens L, Aduc T, Wesley D, Cooper PA. HIV-1 co-infection in children hospitalised with tuberculosis in South Africa. Int J Tuberc Lung Dis 2000;4:448-54.
4. Mukadi YD, Wiktor SZ, Coulibaly IM, et al. Impact of HIV infection on the development, clinical presentation, and outcome of tuberculosis among children in Abidjan, Cote d'Ivoire. AIDS 1997;11:1151-8.
5. De Cock KM, Soro B, Coulibaly IM, Lucas SB. Tuberculosis and HIV infection in sub-Saharan Africa. JAMA 1992;268:1581-7.
6. Haas DW, Des Prez RM. Tuberculosis and acquired immunodeficiency syndrome: A historical perspective on recent developments. Am J Med 1994;96:439-50.
7. Chan SP,Birnbaum J, Rao M, Steiner P. Clinical manifestation and outcome of tuberculosis in children with acquired immunodeficiency syndrome. Pediatr Infect Dis J 1996;15:443-7.
8. Gutman LT, Moye J, Zimmer B, Tian C. Tuberculosis in human immunodeficiency virus-exposed or -infected United States children. Pediatr Infect Dis J 1994;13:963-8.
9. Khouri YF, Mastrucci MT, Hutto C, Mitchell CD, Scott GB. Mycobacterium tuberculosis in children with human immunodeficiency virus type 1 infection. Pediatr Infect Dis J 1992;11:950-5.
10. Thomas MG, Ellis-Pegler RB. Tuberculosis in those with HIV infection. N Z Med J 1997;110:352-4.
11. Chintu C, Bhat G, Luo C, et al. Seroprevalence of human immunodeficiency virus type 1 infection in Zambian children with tuberculosis. Pediatr Infect Dis J 1993;12:499-504.
12. Jeena PM, Mitha T, Bamber S, Wesley A, Coutsoudis A, Coovadia HM. Effects of the human immunodeficiency virus on tuberculosis in children. Tuberc Lung Dis 1996;77:437-43.
13. Sassan-Morokro M, De Cock KM, Ackah A, et al. Tuberculosis and HIV infection in children in Abidjan, Cote d'Ivoire. Trans R Soc Trop Med Hyg 1994;88:178-81.
14. Osborne CM. The challenge of diagnosing childhood tuberculosis in a developing country. Arch Dis Child 1995;72:369-74.
15. Hershfield E. Tuberculosis in children: Guidelines for diagnosis, prevention and management (a statement of the scientific committees of the IUATLD). Bull Int Union Tuberc Lung Dis 1991;66:61-7.
16. Ghidey Y, Habte D. Tuberculosis in childhood: An analysis of 412 cases. Ethiop Med J 1983;21:161-7.
17. Migliori GB, Borghesi A, Rossanigo P, et al. Proposal of an improved score method for the diagnosis of pulmonary tuberculosis in childhood in developing countries [see comments]. Tuber Lung Dis 1992;73:145-9.
18. van Beekhuizen HJ. Tuberculosis score chart in children in Aitape, Papua New Guinea. Trop Doct 1998;28:155-60.
19. Lepage P, Spira R, Kalibala S, et al. Care of human immunodeficiency virus-infected children in developing countries: International Working Group on Mother-to-Child Transmission of HIV. Pediatr Infect Dis J 1998;17:581-6.
20. Palme IB, Gudetta B, Degefu H, Bruchfeld J, Muhe L, Giesecke J. Risk factors for human immunodeficiency virus infection in Ethiopian children with tuberculosis. Pediatr Infect Dis J 2001;20:1066-72.
21. World Health Organization. Provisional guidelines for the diagnosis and classification of the EPI target diseases for primary health care, surveillance and special studies. EPI/GEN 1983:83.
22. WHO Global Data Base on Child Growth and Malnutrition. January. Available at www.who.int/nutgrowthdb. Accessed May 10, 2002.
23. Ministry of Health. Guideline for the National Tuberculosis Control Programme in Ethiopia. Addis Ababa, 1992.
24. Enarson DA. The International Union Against Tuberculosis and Lung Disease model National Tuberculosis Programmes. Tuberc Lung Dis 1995;76:95-9.
25. Chintu C, Luo C, Bhat G, Raviglione M, DuPont H, Zumla A. Cutaneous hypersensitivity reactions due to thiacetazone in the treatment of tuberculosis in Zambian children infected with HIV-1. Arch Dis Child 1993;68:665-8.
26. Nunn P, Kibuga D, Gathua S, et al. Cutaneous hypersensitivity reactions due to thiacetazone in HIV-1 seropositive patients treated for tuberculosis [see comments]. Lancet 1991;337:627-30.
27. Lyamuya E, Bredberg-Raden U, Massawe A, et al. Performance of a modified HIV-1 p24 antigen assay for early diagnosis of HIV-1 infection in infants and prediction of mother-to-infant transmission of HIV-1 in Dar es Salaam, Tanzania. J Acquir Immune Defic Syndr Hum Retrovir 1996;12:421-6.
28. Degefu H, Gudetta B, Muhe L, Beyene H. The pattern of childhood tuberculosis at the EthioSwedish-Children's Hos-pital. Ethiop J Health Dev 1998;12:245-51.
29. Hylander NO. Tuberculosis among children in Ethiopia. Ethiop Med J 1963;2:77-84.
30. Harries AD, Maher D, Nunn P. An approach to the problems of diagnosing and treating adult smear-negative pulmonary tuberculosis in high-HIV-prevalence settings in sub-Saharan Africa. Bull World Health Organ 1998;76:651-62.
31. Kiwanuka J, Graham SM, Coulter JB, et al. Diagnosis of pulmonary tuberculosis in children in an HIV-endemic area, Malawi. Ann Trop Paediatr 2001;21:5-14.
32. Ruffini DD, Madhi SA. The high burden of Pneumocystis carinii pneumonia in African HIV-1-infected children hospitalized for severe pneumonia. AIDS 2002;16:105-12.
33. Miller TL. Nutritional interventions in pediatric HIV: It's hard to hit a moving target. J Pediatr Gastroenterol Nutr 2002;34:32353-6.
34. Graham SM, Daley HM, Banerjee A, Salaniponi FM, Harries AD. Ethambutol in tuberculosis: Time to reconsider? Arch Dis Child 1998;79:274-8.
35. Control of tuberculosis in the United States. American Thoracic Society. Am Rev Respir Dis 1992;146:1623-33.